These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18514370)

  • 21. CTA1-DD adjuvant promotes strong immunity against human immunodeficiency virus type 1 envelope glycoproteins following mucosal immunization.
    Sundling C; Schön K; Mörner A; Forsell MNE; Wyatt RT; Thorstensson R; Hedestam GBK; Lycke NY
    J Gen Virol; 2008 Dec; 89(Pt 12):2954-2964. PubMed ID: 19008380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcytosis-blocking abs elicited by an oligomeric immunogen based on the membrane proximal region of HIV-1 gp41 target non-neutralizing epitopes.
    Matoba N; Griffin TA; Mittman M; Doran JD; Alfsen A; Montefiori DC; Hanson CV; Bomsel M; Mor TS
    Curr HIV Res; 2008 May; 6(3):218-29. PubMed ID: 18473785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CBD1 peptide corresponding to the caveolin-1 binding domain of HIV-1 glycoprotein gp41 elicits neutralizing antibodies in cynomolgus macaques when administered with the tetanus T helper epitope.
    Benferhat R; Martinon F; Krust B; Le Grand R; Hovanessian AG
    Mol Immunol; 2009 Feb; 46(4):705-12. PubMed ID: 19010547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination against drug resistance in HIV infection.
    Boberg A; Isaguliants M
    Expert Rev Vaccines; 2008 Feb; 7(1):131-45. PubMed ID: 18251699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
    Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
    Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. V3 CTL epitope density in a single recombinant molecule antigen differentially affects the number and activity of primary and memory CD8+ T cells.
    Lu L; Zhu Y; Diao J; Wang Z; Chen YH
    Vaccine; 2008 Feb; 26(6):845-52. PubMed ID: 18191003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sublingual immunization with an HIV subunit vaccine induces antibodies and cytotoxic T cells in the mouse female genital tract.
    Hervouet C; Luci C; Cuburu N; Cremel M; Bekri S; Vimeux L; Marañon C; Czerkinsky C; Hosmalin A; Anjuère F
    Vaccine; 2010 Aug; 28(34):5582-90. PubMed ID: 20600505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clarification of how HIV-1 DNA and protein immunizations may be better used to obtain HIV-1-specific mucosal and systemic immunity.
    Hinkula J
    Expert Rev Vaccines; 2007 Apr; 6(2):203-12. PubMed ID: 17408370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA.
    Holmgren J; Adamsson J; Anjuère F; Clemens J; Czerkinsky C; Eriksson K; Flach CF; George-Chandy A; Harandi AM; Lebens M; Lehner T; Lindblad M; Nygren E; Raghavan S; Sanchez J; Stanford M; Sun JB; Svennerholm AM; Tengvall S
    Immunol Lett; 2005 Mar; 97(2):181-8. PubMed ID: 15752556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of multiepitopic and long-lasting immune responses against tumour antigens by immunization with peptides, DNA and recombinant adenoviruses expressing minigenes.
    Durántez M; López-Vázquez AB; de Cerio AL; Huarte E; Casares N; Prieto J; Borrás-Cuesta F; Lasarte JJ; Sarobe P
    Scand J Immunol; 2009 Feb; 69(2):80-9. PubMed ID: 19144076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutralizing activity and cellular immune responses induced in mice after immunization with apoptotic HIV-1/murine leukemia virus infected cells.
    Hinkula J; Walther-Jallow L; Laurén A; Mäkitalo B; Oberg M; Wahren B; Fenyö EM; Spetz AL
    Vaccine; 2009 Oct; 27(46):6424-31. PubMed ID: 19549607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
    Kundu J; Mazumder R; Srivastava R; Srivastava BS
    FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of liposomes possessing surface-linked recombinant B subunit of cholera toxin as an oral antigen delivery system.
    Harokopakis E; Hajishengallis G; Michalek SM
    Infect Immun; 1998 Sep; 66(9):4299-304. PubMed ID: 9712781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic mobilization of antigen presenting cells, with a chimeric Flt-3 and G-CSF receptor agonist, during immunization of Macaca mulatta with HIV-1 antigens is insufficient to modulate immune responses or vaccine efficacy.
    Koopman G; Mortier D; Niphuis H; Farese AM; Kahn LE; Mann D; Wagner R; MacVittie TJ; Woulfe SL; Heeney JL
    Vaccine; 2005 Jul; 23(33):4195-202. PubMed ID: 15896883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insertion of a HIV-1-neutralizing epitope in a surface-exposed internal region of the cholera toxin B-subunit.
    Bäckström M; Lebens M; Schödel F; Holmgren J
    Gene; 1994 Nov; 149(2):211-7. PubMed ID: 7525413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Candidate HIV-1 gp140DeltaV2, Gag and Tat vaccines protect against experimental HIV-1/MuLV challenge.
    Bråve A; Hinkula J; Cafaro A; Eriksson LE; Srivastava IK; Magnani M; Ensoli B; Barnett SW; Wahren B; Rollman E
    Vaccine; 2007 Sep; 25(39-40):6882-90. PubMed ID: 17707956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A two-codon mutant of cholera toxin lacking ADP-ribosylating activity functions as an effective adjuvant for eliciting mucosal and systemic cellular immune responses to peptide antigens.
    Lomada D; Gambhira R; Nehete PN; Guhad FA; Chopra AK; Peterson JW; Sastry KJ
    Vaccine; 2004 Dec; 23(4):555-65. PubMed ID: 15530705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Priming immune response to cholera toxin induced by synthetic peptides.
    Jacob CO; Grossfeld S; Sela M; Arnon R
    Eur J Immunol; 1986 Sep; 16(9):1057-62. PubMed ID: 3758153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reverse transcriptase-based DNA vaccines against drug-resistant HIV-1 tested in a mouse model.
    Isaguliants MG; Zuber B; Boberg A; Sjöstrand D; Belikov SV; Rollman E; Zuber AK; Rechinsky VO; Rytting AS; Källander CF; Hinkula J; Kochetkov SN; Liu M; Wahren B
    Vaccine; 2004 Apr; 22(13-14):1810-9. PubMed ID: 15068865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B.
    Yu S; Feng X; Shu T; Matano T; Hasegawa M; Wang X; Ma H; Li H; Li Z; Zeng Y
    Vaccine; 2008 Nov; 26(48):6124-31. PubMed ID: 18812199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.